AIP
ALXO icon

Ameritas Investment Partners’s ALX Oncology ALXO Stock Holding History

Ameritas Investment Partners’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,790
Closed -$1.74K – 3205
2025
Q1 		$1.74K Hold
2,790
– – ﹤0.01% 3077
2024
Q4 		$4.66K Hold
2,790
– – ﹤0.01% 3034
2024
Q3 		$5.08K Hold
2,790
– – ﹤0.01% 3035
2024
Q2 		$16.8K Hold
2,790
– – ﹤0.01% 2690
2024
Q1 		$31.1K Hold
2,790
– – ﹤0.01% 2385
2023
Q4 		$41.5K Buy
2,790
+1,371
+97% +$13K ﹤0.01% 2276
2023
Q3 		$6.81K Hold
1,419
– – ﹤0.01% 2932
2023
Q2 		$10.7K Hold
1,419
– – ﹤0.01% 2893
2023
Q1 		$6.41K Hold
1,419
– – ﹤0.01% 2821
2022
Q4 		$12.9K Hold
1,419
– – ﹤0.01% 2731
2022
Q3 		$13K Hold
1,419
– – ﹤0.01% 2699
2022
Q2 		$11K Hold
1,419
– – ﹤0.01% 2798
2022
Q1 		$24K Hold
1,419
– – ﹤0.01% 2470
2021
Q4 		$30K Hold
1,419
– – ﹤0.01% 2429
2021
Q3 		$105K Hold
1,419
– – ﹤0.01% 1657
2021
Q2 		$78K Hold
1,419
– – ﹤0.01% 1885
2021
Q1 		$105K Buy
1,419
+603
+74% +$47.4K ﹤0.01% 1638
2020
Q4 		$70K Hold
816
– – ﹤0.01% 1774
2020
Q3 		$31K Buy
+816
New +$32.1K ﹤0.01% 2133

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Ameritas Investment Partners's ALXO Position: Q2 2025 in Review

Ameritas Investment Partners sold out of ALX Oncology (ALXO) in Q2 2025, closing a stake of 2,790 shares — an estimated $1.74K sold.

Ameritas Investment Partners first reported a position in ALXO in Q3 2020 and held it in 19 quarters. The position peaked at $105K in Q3 2021. 61 funds tracked by Wall St. Rank hold ALXO as of Q2 2025.

  • Ameritas Investment Partners reported no remaining ALX Oncology position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 2,790 ALX Oncology shares in Q2 2025, an estimated $1.74K.
  • Ameritas Investment Partners first reported a position in ALX Oncology in Q3 2020 and held it in 19 quarters.
  • Ameritas Investment Partners's ALX Oncology position peaked at $105K in Q3 2021.
  • 61 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.